Amidst the global pandemic, there was an urgent need to manufacture Covid vaccines across the globe. In this scenario, the pharma company Catalent converted one of its aseptic processing lines, which specialized in powder processing, to liquid processing. The move helped the firm to produce its first commercial batch of Covid vaccines in April 2021.
Read on